About Linnie Chang
Linnie is the Vice President of Finance at Genezen and leads the finance and accounting functions. She brings a wealth of industry experience to her role. Previously, she served as the Sr. Director of Finance at Orum Therapeutics, a clinical stage biotech company known for its novel class of protein degraders. Before that, she was the Controller at Arranta Bio, a leading CDMO for mRNA, from its inception in 2019 until its successful acquisition by Recipharm in February 2022. Linnie has also held positions at publicly traded bio-pharmaceutical companies during times of rapid growth and transformation, where she implemented processes to maximize efficiency and provide better financial visibility to internal and external stakeholders. Linnie is a Certified Public Accountant and began her career as an auditor with KPMG, where she worked with multinational SEC clients. She holds a Bachelor’s and Master’s degree in Accounting from the University of Massachusetts Amherst.
I chose to join Genezen because I am excited about the opportunity to be part of a dynamic and forward-thinking organization dedicated to improving people’s lives.
My Greatest Passion:
I’m lucky to be someone that can say “I love what I do” – I am passionate about bringing positive impact to people’s lives and have always loved numbers and their ability to tell stories. I find working with teams and translating data into insights that can drive strategic decision-making incredibly fulfilling, as it is using my skills to ultimately transform the lives of many.
Meet our People
Our team is dedicated to getting your viral vector where it needs to go. Communication and collaboration are part of our DNA and we can't wait to talk to you about your current challenges and needs.